Skip to content
Riskpilot
← Back to search
Sign in
Get full access
UCB PHARMA AS
AS
Active
Org 976281918
Haakon Viis Gate 6, 0161
Oslo
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1996
5 employees
Watchlist
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
UCB PHARMA AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
FA
Fredrik Arneberg
Chief Executive Officer
Chief Executive Officer
2022
Former (1)
HD
Henrik Dramer Bøgebjerg Hansen
Chief Executive Officer
Chief Executive Officer
2017 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
JM
Jaana Mattila
Board of Directors
2025
CD
Christina Dyreborg Jeppesen
Chairman
2025
Former (4)
AI
Ana Isabel Infante Gonzalez De La Aleja
Board of Directors
2022 – 2025
AR
Afshin Risseh
Chairman
2022 – 2025
PO
Per Ove Jonas Berg
Board of Directors
2022 – 2025
IV
Ilaria Villa
Board of Directors
2020 – 2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Ucb Pharma Sa
Company
100%
100%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on UCB PHARMA AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network